EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Estimating causality between smoking and abdominal obesity by Mendelian randomization

Germán D Carrasquilla iD, Mario García-Ureña, María J Romero-Lado, Tuomas O Kilpeläinen iD

Addiction · 2024-06 · 119 (6) · 1024-1034

DOI: 10.1111/add.16454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addiction, online erschienen am 20.03.2024. Verfasst von Germán D Carrasquilla und 3 weiteren Autor:innen. Beteiligte Einrichtung: Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Mendelian Randomization Analysis, Obesity, Abdominal, Genome-Wide Association Study, Causality. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novo Nordisk Fonden, H2020 Marie Skłodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Smokers tend to have a lower body weight than non‐smokers, but also more abdominal fat. It remains unclear whether or not the relationship between smoking and abdominal obesity is causal. Previous Mendelian randomization (MR) studies have investigated this relationship by relying upon a single genetic variant for smoking heaviness. This approach is sensitive to pleiotropic effects and may produce imprecise causal estimates. We aimed to estimate causality between smoking and abdominal obesity using multiple genetic instruments.

Design

MR study using causal analysis using summary effect estimates (CAUSE) and latent heritable confounder MR (LHC‐MR) methods that instrument smoking using genome‐wide data, and also two‐sample MR (2SMR) methods.

Setting

Genome‐wide association studies (GWAS) summary statistics from participants of European ancestry, obtained from the GWAS and Sequencing Consortium of Alcohol and Nicotine use (GSCAN), Genetic Investigation of Anthropometric Traits (GIANT) Consortium and the UK Biobank.

Participants

We used GWAS results for smoking initiation ( n = 1 232 091), life‐time smoking ( n = 462 690) and smoking heaviness ( n = 337 334) as exposure traits, and waist–hip ratio (WHR) and waist and hip circumferences (WC and HC) ( n up to 697 734), with and without adjustment for body mass index (adjBMI), as outcome traits.

Measurements

Smoking initiation, life‐time smoking, smoking heaviness, WHR, WC, HC, WHR adjBMI , WC adjBMI and HC adjBMI .

Findings

Both CAUSE and LHC‐MR indicated a positive causal effect of smoking initiation on WHR (0.13 [95% confidence interval (CI) = 0.10, 0.16 and 0.49 (0.41, 0.57), respectively] and WHR adjBMI (0.07 (0.03, 0.10) and 0.31 (0.26, 0.37). Similarly, they indicated a positive causal effect of life‐time smoking on WHR [0.35 (0.29, 0.41) and 0.44 (0.38, 0.51)] and WHR adjBMI [0.18 (0.13, 0.24) and 0.26 (0.20, 0.31)]. In follow‐up analyses, smoking particularly increased visceral fat. There was no evidence of a mediating role by cortisol or sex hormones.

Conclusions

Smoking initiation and higher life‐time smoking may lead to increased abdominal fat distribution. The increase in abdominal fat due to smoking is characterized by an increase in visceral fat. Thus, efforts to prevent and cease smoking can have the added benefit of reducing abdominal fat.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mendelian Randomization AnalysisObesity, AbdominalGenome-Wide Association StudyCausalitySmokingWaist-Hip RatioHumansFemaleMaleMiddle AgedAdult

Stichwörter der Autor:innen

Abdominal obesityMendelian randomizationcigarette smokinggenetic analysisobesitysmoking

Autor:innen und Institutionen

  • Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

ORCID-Profile: Germán D Carrasquilla, Tuomas O Kilpeläinen

Förderung

  • Novo Nordisk Fonden
  • H2020 Marie Skłodowska-Curie Actions

Zitieren

APA

Carrasquilla, G. D., García-Ureña, M., Romero-Lado, M. J., & Kilpeläinen, T. O. (2024). Estimating causality between smoking and abdominal obesity by Mendelian randomization. Addiction, 119(6), 1024-1034. https://doi.org/10.1111/add.16454

Vancouver

Carrasquilla GD, García-Ureña M, Romero-Lado MJ, Kilpeläinen TO. Estimating causality between smoking and abdominal obesity by Mendelian randomization. Addiction. 2024;119(6):1024-1034. doi:10.1111/add.16454

BibTeX
@article{Carrasquilla2024,
  author = {Carrasquilla, Germán D and García-Ureña, Mario and Romero-Lado, María J and Kilpeläinen, Tuomas O},
  title = {Estimating causality between smoking and abdominal obesity by Mendelian randomization},
  journal = {Addiction},
  year = {2024},
  volume = {119},
  number = {6},
  pages = {1024--1034},
  doi = {10.1111/add.16454}
}
Kostenlos starten →